Sort
48,018 grants matching “immunotherapy”
Enhancing efficacy of vaccines for substance abuse through polymer-assisted delivery of immunomodulators
$439,201Marco Pravetoni · Hennepin Healthcare Research Institute · R01 · FY2016 · DA
Optimization of RORgamma-specific agonists as immune activators for a new immunotherapy approach for cancer
$439,200Patrick Robert Griffin · Scripps Florida · R01 · FY2017 · CA
Optimization of RORgamma-specific agonists as immune activators for a new immunotherapy approach for cancer
$439,200Patrick Robert Griffin · Scripps Florida · R01 · FY2016 · CA
Optimization of RORgamma-specific agonists as immune activators for a new immunotherapy approach for cancer
$439,200Patrick Robert Griffin · Scripps Florida · R01 · FY2018 · CA
Targeting TERT in Melanoma
$439,183Jessie Villanueva · Wistar Institute · R01 · FY2017 · CA
Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1
$439,100Rong Li · George Washington University · R01 · FY2024 · CA
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs
$439,092Sana D Karam · University Of Colorado Denver · R01 · FY2021 · DE
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs
$439,092Sana D Karam · University Of Colorado Denver · R01 · FY2020 · DE
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs
$439,092Sana D Karam · University Of Colorado Denver · R01 · FY2019 · DE
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs
$439,092Sana D Karam · University Of Colorado Denver · R01 · FY2023 · DE
Dendritic Cell-Based Immunotherapy for HIV Infection
$439,045University Of Pittsburgh At Pittsburgh · P01 · FY2003 · AI
Data Management and Analysis Core
$439,035Aris Floratos · Columbia University Health Sciences · U19 · FY2020 · AI
Using Nonclassical Estrogen Signaling to Prevent Melanoma
$438,974Todd W Ridky · University Of Pennsylvania · R01 · FY2021 · CA
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-I
$438,958Sun Hur · Boston Children'S Hospital · R01 · FY2014 · AI
BET degraders for improving colorectal cancer therapy
$438,915Lin Zhang · University Of Southern California · R01 · FY2025 · CA
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT) - DCC
$438,909Susanne May · University Of Washington · U01 · FY2019 · HL
Basophil phenotype & activation in peanut allergy and oral Immunotherapy
$438,843Stephen J Galli · Stanford University · U19 · FY2015 · AI
DNA damage response and cancer immunity
$438,804Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
$438,800Hassane M Zarour · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · CA
Repertoire selection of AQP4-specific T cells that cause CNS autoimmunedisease
$438,798Scott S Zamvil · University Of California, San Francisco · R01 · FY2021 · AI
Treatment of RSV Bronchiolitis with NSAIDs
$438,794Jorge C Blanco · Virion Systems, Inc. · R43 · FY2006 · AI
Cell and Gene Therapy, Clinical Manufacture and Monitoring Core
$438,766Antoni Ribas · California Institute Of Technology · P01 · FY2013 · CA
Treatment/Type 1 Diabetes/hGAD65 Altered Peptide Ligand
$438,750Benaroya Research Inst At Virginia Mason · R21 · FY2003 · DK
Development of mAb therapeutics against biothreat and emerging diease agents
$438,736Thomas Briese · Columbia University Health Sciences · U54 · FY2009 · AI
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
$438,732Taha Merghoub · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA